Ombrabulin (AVE8062)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ombrabulin (AVE8062), covering 2015-12-21 to 2015-12-21. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer [Phase 2]